LUMAXIND evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-21T13:56:04.538007+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 41841593000.0
- net_income
- 1724689000.0
- operating_cash_flow
- 3347118000.0
- free_cash_flow
- 452810000.0
- total_assets
- 34350993000.0
- total_liabilities
- 25175950000.0
- total_equity
- 9175043000.0
- cash
- 262347000.0
- total_debt
- 9731290000.0
- revenue_growth
- 0.24726799388337306
- earnings_growth
- 0.23272462684593598
- net_margin
- 0.041219487030524866
- roe
- 0.18797612174678635
- debt_to_equity
- 1.0606260918886157
- cash_conversion
- 1.940708150860822
- free_cash_flow_margin
- 0.01082200670514624
- trailing_pe
- 31.56
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-28dc126b6e8a48230cb93af58c0c318cfe36d6afc652a75a7d755450e7183eb3
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 4537d144467db3e6a10ad4226661607dd33d54c631b126fcff8aecdbeb16dd79
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 9594a21739e0ba588aadc5aea1282b7f36a337e471787514e0888a617b78a3f9
- daily-price: 2df56f28b0ff4966d70d0145bc6218aee5a94612f01e32c5e84e36a655ffd7e4
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 5550.00.
- The trailing 5-session price return was -3.18%.
- The trailing 20-session price return was -12.56%.
- The trailing 60-session price return was 6.80%.
- The trailing 250-session price return was 17.48%.
- Average cached traded value over twenty sessions was INR 79,749,622.
- The closing price was -16.41% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-21T13:56:04.538007+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.24726799388337306.
- The cached financial metric net margin is 0.041219487030524866.
- The cached financial metric roe is 0.18797612174678635.
- The cached financial metric debt to equity is 1.0606260918886157.
- The cached financial metric cash conversion is 1.940708150860822.
- The cached financial metric free cash flow margin is 0.01082200670514624.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.